研報掘金丨中銀證券:維持欣旺達“增持”評級,“對等關稅”影響有限
中銀證券研報指出,美國宣佈對華加徵“對等關稅”引發市場對公司業績擔憂,欣旺達(300207.SZ)於互動問答平臺表示加徵關稅對公司影響較小。公司傳統核心業務穩健發展,動力和儲能電池業務成長性值得期待;維持“增持”評級。根據公司2024年半年報披露,上半年公司國外營收96.85億元,佔營收比例40.49%;毛利潤8.94億元,佔毛利潤比例22.53%。美國“對等關稅”政策頒佈後,公司於互動問答平臺澄清,公司產品出口形式主要爲出口到保稅倉,直接出口美國比例極小,關稅對公司影響較小。隨着手機市場需求復甦及公司進一步開拓客戶,疊加自供率提升,公司消費電池業務盈利水平具備進一步提升空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.